EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

WEEKLY VERSUS TRI-WEEKLY CONCURRENT CISPLATIN WITH RADIOTHERAPY IN THE TREATMENT OF CERVICAL CANCER: A STUDY COMPARING EFFICACY AND TOXICITY

Khushbu Sharma, Piyush Kumar, D. P. Singh, Arvind Kumar Chauhan, Kamal Sahni

SRMS JOURNAL OF MEDICAL SCIENCE · 2016

DOI: 10.21761/jms.v1i2.7122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SRMS JOURNAL OF MEDICAL SCIENCE, 2016. Verfasst von Khushbu Sharma und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Concurrent chemoradiation is the standard treatment for the locally advanced cervical cancer. The optimal Cisplatin dose and dosing schedule are still undetermined. The present study aims to evaluate the efficacy and toxicity of weekly and tri-weekly cisplatin with radiotherapy in treatment of cervical cancer. Material And Methods: Fifty patients with histologically proven Stage IA-IIIB cervical cancer were randomly assigned to weekly (Arm 1, cisplatin 35 mg/m2, five cycles) and tri- weekly (Arm 2, cisplatin 75 mg/m2 every 3 weeks, two cycles) chemotherapy during radiotherapy. The difference of efficacy and toxicity profiles between the two regimens was investigated, and the response rate was analyzed.

Results

All patients tolerated both treatments well. There was significantly better chemotherapy compliance in tri-weekly arm (100% vs 68%, p=0.002). Leucopenia was higher in ARM-B then ARM-A (16% vs 4%, p=0.15). Vomiting grade II/III was significantly higher in ARM-B then ARM-A (64% vs 24%, p=0.009). Grade II Genito-urinary toxicity was higher in ARM-B then ARM-A (20% vs 4%, statistically not significant).

Conclusion

Both weekly cisplatin 35 mg/m2 and tri-weekly 75 mg/m2 concurrent with radiotherapy are equally feasible and efficacious.

Zitieren

APA

Sharma, K., Kumar, P., Singh, D. P., Chauhan, A. K., & Sahni, K. (2016). WEEKLY VERSUS TRI-WEEKLY CONCURRENT CISPLATIN WITH RADIOTHERAPY IN THE TREATMENT OF CERVICAL CANCER: A STUDY COMPARING EFFICACY AND TOXICITY. SRMS JOURNAL OF MEDICAL SCIENCE. https://doi.org/10.21761/jms.v1i2.7122

Vancouver

Sharma K, Kumar P, Singh DP, Chauhan AK, Sahni K. WEEKLY VERSUS TRI-WEEKLY CONCURRENT CISPLATIN WITH RADIOTHERAPY IN THE TREATMENT OF CERVICAL CANCER: A STUDY COMPARING EFFICACY AND TOXICITY. SRMS JOURNAL OF MEDICAL SCIENCE. 2016. doi:10.21761/jms.v1i2.7122

BibTeX
@article{Sharma2016,
  author = {Sharma, Khushbu and Kumar, Piyush and Singh, D. P. and Chauhan, Arvind Kumar and Sahni, Kamal},
  title = {WEEKLY VERSUS TRI-WEEKLY CONCURRENT CISPLATIN WITH RADIOTHERAPY IN THE TREATMENT OF CERVICAL CANCER: A STUDY COMPARING EFFICACY AND TOXICITY},
  journal = {SRMS JOURNAL OF MEDICAL SCIENCE},
  year = {2016},
  doi = {10.21761/jms.v1i2.7122}
}
Kostenlos starten →